Rybova et al. demonstrated that hematopoietic stem cell transplantation prevented disease progression and spinal demyelination in a mouse model of spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME) caused by acid ceramidase (ACDase) deficiency, improving behavioral outcomes (85). Here, ASAH1 is linked to progressive myoclonus epilepsy.